Cargando…

Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group

BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar-Amini, Maral, Mahmoudi, Mahmoud, Dadgarmoghaddam, Maliheh, Farzad, Faramarz, Najafabadi, Ali Qaraee, Jabbari-Azad, Farahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542492/
https://www.ncbi.nlm.nih.gov/pubmed/34694544
http://dx.doi.org/10.1007/s10875-021-01149-6
_version_ 1784589442278752256
author Barzegar-Amini, Maral
Mahmoudi, Mahmoud
Dadgarmoghaddam, Maliheh
Farzad, Faramarz
Najafabadi, Ali Qaraee
Jabbari-Azad, Farahzad
author_facet Barzegar-Amini, Maral
Mahmoudi, Mahmoud
Dadgarmoghaddam, Maliheh
Farzad, Faramarz
Najafabadi, Ali Qaraee
Jabbari-Azad, Farahzad
author_sort Barzegar-Amini, Maral
collection PubMed
description BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with mild or no symptoms as the (outpatient group), and 203 healthy subjects with negative specific serology, as the control group were investigated. The cases’ laboratory data were collected, and thereafter, statistical tests, including independent samples t test, ANOVA test, and post hoc test, were performed using SPSS software version 22. RESULT: The mean ± SD of IgA in all the included subjects was 2.23 ± 0.78 (g/L). According to the obtained results, there were statistically significant changes in IgA among the three study groups (P value < 0.05). This difference was significant between both outpatient and inpatient groups (P value < 0.05). The mean ± SD of serum IgG in all the subjects was calculated as 15.83 ± 5.73 (g/L). A strong statistically significant change was also seen in IgG among all three groups (P value < 0.001). Of note, there was a significant negative correlation between IgG and IgA total titers of the outpatient group (P value = 0.011*r =  − 0.188). CONCLUSION: It was shown that the total serum IgA and IgG levels are significantly associated with the severity of COVID-19 infection. As well, we found that total serum IgA and IgG are associated with the severity of illness. Since a low level of IgA is asymptomatic and high frequent in Iran and other countries, we suggest the evaluation of serum IgA levels in high-risk people and strengthening immune system in subjects with a low level of IgA, in order to reduce the rate of death. In this regard, oral or nasal mucosal vaccines in combination with parenteral vaccination are recommended due to increasing immunity versus COVID-19 by further secretion of the IgA antibody and preventing virus transmission.
format Online
Article
Text
id pubmed-8542492
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85424922021-10-25 Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group Barzegar-Amini, Maral Mahmoudi, Mahmoud Dadgarmoghaddam, Maliheh Farzad, Faramarz Najafabadi, Ali Qaraee Jabbari-Azad, Farahzad J Clin Immunol Original Article BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with mild or no symptoms as the (outpatient group), and 203 healthy subjects with negative specific serology, as the control group were investigated. The cases’ laboratory data were collected, and thereafter, statistical tests, including independent samples t test, ANOVA test, and post hoc test, were performed using SPSS software version 22. RESULT: The mean ± SD of IgA in all the included subjects was 2.23 ± 0.78 (g/L). According to the obtained results, there were statistically significant changes in IgA among the three study groups (P value < 0.05). This difference was significant between both outpatient and inpatient groups (P value < 0.05). The mean ± SD of serum IgG in all the subjects was calculated as 15.83 ± 5.73 (g/L). A strong statistically significant change was also seen in IgG among all three groups (P value < 0.001). Of note, there was a significant negative correlation between IgG and IgA total titers of the outpatient group (P value = 0.011*r =  − 0.188). CONCLUSION: It was shown that the total serum IgA and IgG levels are significantly associated with the severity of COVID-19 infection. As well, we found that total serum IgA and IgG are associated with the severity of illness. Since a low level of IgA is asymptomatic and high frequent in Iran and other countries, we suggest the evaluation of serum IgA levels in high-risk people and strengthening immune system in subjects with a low level of IgA, in order to reduce the rate of death. In this regard, oral or nasal mucosal vaccines in combination with parenteral vaccination are recommended due to increasing immunity versus COVID-19 by further secretion of the IgA antibody and preventing virus transmission. Springer US 2021-10-25 2022 /pmc/articles/PMC8542492/ /pubmed/34694544 http://dx.doi.org/10.1007/s10875-021-01149-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Barzegar-Amini, Maral
Mahmoudi, Mahmoud
Dadgarmoghaddam, Maliheh
Farzad, Faramarz
Najafabadi, Ali Qaraee
Jabbari-Azad, Farahzad
Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title_full Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title_fullStr Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title_full_unstemmed Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title_short Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
title_sort comparison of serum total iga levels in severe and mild covid-19 patients and control group
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542492/
https://www.ncbi.nlm.nih.gov/pubmed/34694544
http://dx.doi.org/10.1007/s10875-021-01149-6
work_keys_str_mv AT barzegaraminimaral comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup
AT mahmoudimahmoud comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup
AT dadgarmoghaddammaliheh comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup
AT farzadfaramarz comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup
AT najafabadialiqaraee comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup
AT jabbariazadfarahzad comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup